EGFR and liver cancer: This cancer-targeted design of bee venom-CSNPs presents a new technique for treating liver cancer in vitro and in vivo with greater efficacy and fewer side effects than native bee venom, implying that targeted bee venom-CSNPs should be studied further as a chemotherapeutic agent for human malignancies, particularly EGFR over-expressed tumors.